Drug Repurposing of Bromodomain Inhibitors as Potential Novel Therapeutic Leads for Lymphatic Filariasis Guided by Multispecies Transcriptomics
The current treatment regimen for lymphatic filariasis is mostly microfilaricidal. In an effort to identify new drug candidates for lymphatic filariasis, we conducted a three-way transcriptomics/systems biology study of one of the causative agents of lymphatic filariasis, Brugia malayi, its Wolbachi...
Main Authors: | Matthew Chung, Laura E. Teigen, Silvia Libro, Robin E. Bromley, Dustin Olley, Nikhil Kumar, Lisa Sadzewicz, Luke J. Tallon, Anup Mahurkar, Jeremy M. Foster, Michelle L. Michalski, Julie C. Dunning Hotopp |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2019-12-01
|
Series: | mSystems |
Subjects: | |
Online Access: | https://doi.org/10.1128/mSystems.00596-19 |
Similar Items
-
Wandering intravitreal worm of Brugia malayi from Central India
by: Gitumoni Sharma, et al.
Published: (2020-01-01) -
Transcription profiling reveals stage- and function-dependent expression patterns in the filarial nematode <it>Brugia malayi</it>
by: Li Ben-Wen, et al.
Published: (2012-05-01) -
Are C. elegans receptors useful targets for drug discovery: Identification of genes encoding seven potential biogenic amine receptors in the parasitic nematode Brugia malayi and pharmacological comparison of tyramine receptor homologues from Caenorhabditi
by: Smith, Katherine Ann
Published: (2007) -
Hospes Reservoir Dan Suspek Vektor Filariasis Di Desa Muara Padang, Kecamatan Muara Padang, Kabupaten Banyuasin, Sumatera Selatan
by: Erwin Edyansyah, et al.
Published: (2017-08-01) -
In vitro and In vivo Anti-Filarial Effect of Tetracycline/ Doxycycline
by: Subuhi Khan, et al.
Published: (2017-12-01)